Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (701-710 of 869) with videos related to

Pageof 87
Sort By:
Plant Direct|February 9, 2026
Targeting dCas9-SunTag to a Susceptibility Gene Promoter Is Sufficient for CRISPR InterferenceZuh-Jyh Daniel Lin, Gabriela L Hernandez, Myia K Stanton, et al.
Cell Death and Differentiation|November 29, 2014
A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromesP De Groote, H T Tran, M Fransen, et al.
The Lancet. Infectious Diseases|February 25, 2014
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili studyGlenda E Gray, Zoe Moodie, Barbara Metch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trialsMichal Juraska, Craig A Magaret, Jason Shao, et al.
American Journal of Epidemiology|August 21, 2025
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-upEthan Ashby, Holly Janes, Dean Follmann, et al.
The Journal of the American Academy of Orthopaedic Surgeons|July 5, 2024
Prophylactic Antibiotic Choice and Deep Infection in Lower Extremity Endoprosthetic Reconstruction: Comparison of Cefazolin, Cefazolin-Vancomycin, and Alternative RegimensKatherine S Hajdu, Stephen W Chenard, Anthony D Judice, et al.
Plos Computational Biology|February 22, 2020
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trialsDaniel B Reeves, Yunda Huang, Elizabeth R Duke, et al.
Nature Communications|January 5, 2023
Improving cassava bacterial blight resistance by editing the epigenomeKira M Veley, Kiona Elliott, Greg Jensen, et al.
Trials|May 24, 2019
Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaintS Belleville, A Moussard, A I Ansaldo, et al.
Lancet (London, England)|November 18, 2008
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSusan P Buchbinder, Devan V Mehrotra, Ann Duerr, et al.
Pageof 87

Showing results (701-710 of 869) with videos related to

Sort By:
Pageof 87
Plant Direct|February 9, 2026
Targeting dCas9-SunTag to a Susceptibility Gene Promoter Is Sufficient for CRISPR InterferenceZuh-Jyh Daniel Lin, Gabriela L Hernandez, Myia K Stanton, et al.
Cell Death and Differentiation|November 29, 2014
A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromesP De Groote, H T Tran, M Fransen, et al.
The Lancet. Infectious Diseases|February 25, 2014
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili studyGlenda E Gray, Zoe Moodie, Barbara Metch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trialsMichal Juraska, Craig A Magaret, Jason Shao, et al.
American Journal of Epidemiology|August 21, 2025
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-upEthan Ashby, Holly Janes, Dean Follmann, et al.
The Journal of the American Academy of Orthopaedic Surgeons|July 5, 2024
Prophylactic Antibiotic Choice and Deep Infection in Lower Extremity Endoprosthetic Reconstruction: Comparison of Cefazolin, Cefazolin-Vancomycin, and Alternative RegimensKatherine S Hajdu, Stephen W Chenard, Anthony D Judice, et al.
Plos Computational Biology|February 22, 2020
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trialsDaniel B Reeves, Yunda Huang, Elizabeth R Duke, et al.
Nature Communications|January 5, 2023
Improving cassava bacterial blight resistance by editing the epigenomeKira M Veley, Kiona Elliott, Greg Jensen, et al.
Trials|May 24, 2019
Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaintS Belleville, A Moussard, A I Ansaldo, et al.
Lancet (London, England)|November 18, 2008
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSusan P Buchbinder, Devan V Mehrotra, Ann Duerr, et al.
Pageof 87